clinical trial · NCT00840281
Cefprozil 500 mg Tablets Under Fasting Conditions
Teva Pharmaceuticals USA·phase1·completed·n = 38
HealthyCefzil® 500 mg tabletsCefprozil 500 mg Tablets
brief summary
The objective of this study is to compare the relative bioavailability of cefprozil 500 mg tablets (Teva Pharmaceuticals USA) with that of Cefzil® 500 mg tablets (Bristol-Myers Squibb) in healthy, non-smoking adults under fasting conditions.
started
Sep 1, 2003
primary completion
Sep 1, 2003
completion
Sep 1, 2003
last updated
Aug 20, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Relative Bioavailability Study of Cefprozil 500 mg Tablets Under Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol